23and me stock.

Anne Wojcicki is the CEO and Co-Founder of 23andMe. She co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent …

23and me stock. Things To Know About 23and me stock.

A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ...Stock Price Forecast. The 3 analysts offering 12-month price forecasts for 23andMe Holding Co. have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 0.90. The median ...Power to Investors. A high-level overview of 23andMe Holding Co. (ME) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, …See 23andMe Holding Co. (ME) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE ...23andMe’s stock closed down more than 1% percent at $0.86 Friday, continuing a downward trend that first started in October 2021, when the company’s stock was trading at more than $11 per ...

Source: Kantar Media. View the latest 23andMe Holding Co. (ME) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Dec 1, 2023 · To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios. Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on. 23andMe Holding Co. has a Value Score of 51, which is Average. Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE ...Funding. 23andMe has raised a total of. $1.1B. in funding over 19 rounds. Their latest funding was raised on Jun 17, 2021 from a Post-IPO Equity round. 23andMe is registered under the ticker NASDAQ:ME . 23andMe is funded by 39 investors. Richard Branson and Altimeter Capital are the most recent investors. 23andMe has a post-money valuation in ...Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.

Analyst Forecast. According to 3 analysts, the average rating for ME stock is "Strong Buy." The 12-month stock price forecast is $4.92, which is an increase of 455.87% from the latest price.

23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript November 8, 2023 23andMe Holding Co. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14 ...

Compare with up to 5 Stocks. On Friday morning 11/24/2023 the 23andMe Holding Co Registered Shs -A- share started trading at the price of $0.88. Compared to the closing price on Thursday 11/23 ...Nov 21, 2022 · 23andMe Holding Co. ( NASDAQ: ME) is a genomics research company that aims to make genetic testing commonplace and mainstream. The global genomics industry was valued at $27.81 billion in 2021 and ... Dec 4, 2023 11:59 AM PST. By Jon Swartz. Company says it believes breach was the result of customers recycling passwords. DNA-testing company 23andMe confirmed Monday that information about 6.9 ...Jun 18, 2021 · The SPAC merger gave 23andMe an equity value of $4.45 billion, and its stock surge boosted its equity value to around $5.92 billion. After adjusting for its $984 million in pro forma net cash, we ... 22 de out. de 2021 ... ... stock deal, as it looks to expand into telemedicine ... Oct 22 (Reuters) - Direct-to-consumer DNA testing firm 23andMe Holding Co (ME.Asset Growth. -17.98%. Trailing 12-Months. The 23andMe Holding stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and ...

Stock Ticker Symbol Market Type; 23andMe Holding Company: ME: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded . 0.08375: 10.98%: 0.84655: 15:34:42: Open Price Low Price14 de nov. de 2023 ... 23andMe Holding Co. (NASDAQ: ME), the genetic screening company that went public via a SPAC in 2021, received a deficiency letter from the ...23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript November 8, 2023 23andMe Holding Co. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14 ... 10 de jun. de 2021 ... The implied equity value of $3.6 billion includes the value of the options exercisable for shares of New 23andMe Class A Common Stock that are ...27.2%. -28.6%. Market Cap. The market value of a company, in total dollars, also called "market capitalization." Market cap is calculated by taking a company's price per share and multiplying it ...

Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock.ORLANDO, FL - April 14, 2023 -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today announced results from the Phase 1 portion of its Phase 1/2a study evaluating 23ME-00610, an investigational antibody targeting CD200R1. 23ME-00610 demonstrated an acceptable safety and tolerability profile, with favorable pharmacokinetics (PK) and ...

SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, reported its financial results for the first quarter (Q1) of fiscal year 2024 (FY2024), which ended June 30, 2023. 23andMe is the only company with multiple U.S. Food and Drug ...Oct 22, 2021 · Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. Shares of 23andMe Holding ( ME 3.64%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ...Majority of impacted users are now being notified, 23andMe confirmed. It's now been confirmed that an additional 6.9 million 23andMe users had ancestry data …Compare 23andMe DNA Test Kits - Which one is the best for you? Special Bundle Offer: Get two Health + Ancestry Services for $199. Get two Health + Ancestry Services for $199; third Health + Ancestry Service is $109; each additional Health + Ancestry Service is $229. Offer ends Dec 4. Which service do you want.17 de jun. de 2021 ... 23andMe is now listed on the Nasdaq stock exchange as $ME! As a public company, we have the opportunity to expand on our mission and have an ...

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Nov 27, 2023 · 2 Wall Street research analysts have issued 1-year price objectives for 23andMe's shares. Their ME share price targets range from $1.75 to $7.00. On average, they anticipate the company's stock price to reach $4.38 in the next year. This suggests a possible upside of 381.4% from the stock's current price.

23andMe Holding Co. analyst ratings, historical stock prices, earnings estimates & actuals. ME updated stock price target summary. Discover historical prices for ME stock on Yahoo Finance. View daily, weekly or monthly format back to when 23andMe Holding Co. stock was issued. DNA Genetic Testing For Health, Ancestry And More - 23andMe. Special Bundle Offer: Enter your email to unlock two Health + Ancestry Services for $199. Get two Health + Ancestry Services for $199; third Health + Ancestry Service is $109; each additional Health + Ancestry Service is $229. Offer ends Dec 4. Entry of your email address is not ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Anne Wojcicki, co-founder and chief executive officer of 23andme. Some 6.9 million 23andMe customers had their data compromised after an anonymous hacker …22 de out. de 2021 ... ... stock deal, as it looks to expand into telemedicine ... Oct 22 (Reuters) - Direct-to-consumer DNA testing firm 23andMe Holding Co (ME.Asset Growth. -17.98%. Trailing 12-Months. The 23andMe Holding stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and ...This led the company to launch an investigation alongside third-party experts. In light of the investigation, 23andMe now reports that the information that was accessed without authorization is a ...What is 23andMe's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for 23andMe stock is Buy based on the current 1 buy rating for ME. The average twelve-month price prediction for 23andMe is $1.75 with a high price target of $1.75 and a low price target of $1.75.ME - 23andMe Holding Co. Stock quote - CNNMoney.com Tech Media Success Video 23andMe Holding Co. (NASDAQ:ME) 0.8501 Delayed Data As of Nov 17 +0.0873 / …ME Earnings Date and Information. 23andMe last announced its earnings results on November 8th, 2023. The reported ($0.16) EPS for the quarter. The company had revenue of $50 million for the quarter, compared to analyst estimates of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) diluted …Nov 20, 2023 · November 16, 2023. $0.76. 3,664,420. 1:1. $0.86. $0.86. $0.75. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since ...

Anne Wojcicki is the CEO and Co-Founder of 23andMe. She co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent …That includes oncology, respiratory, and cardiovascular diseases. Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands. That’s approaching its average ...23andMe stock valuation (Created by Author Ben Alaimo at Motivation 2 Invest) Given these factors, I get a fair value of $3.57 per share for ME. At the time of writing, the stock is ~$3 per share ...ME. +10.27%. DNA-testing company 23andMe confirmed Monday that information about 6.9 million people, about half of its 14 million customers, was accessed …Instagram:https://instagram. nysearca sgolrcl nasdaqnatron energy stockdental insurance plans ma Oct 17, 2021 · In June, 23andMe ( ME 2.88%) officially finished the process of going public via a special purpose acquisition company ( SPAC ). These investment vehicles were popular in early 2021, but many have ... 23andMe Insider Trading Activity 2023 (NASDAQ:ME) S&P 500 4,556.62. DOW 35,273.03. QQQ 390.06. NVIDIA is 'expensive' for a reason. Don't let it slip by. Important info on NVDA trade (Ad) Medtronic: oversold, overextended high yield reversal in play. Bank stocks soar with these top performers. vmffxbest wealth management firms Analyst Report: 23andMe Holding Co. 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA ... 23andMe Holding Co. Class A Common Stock (ME) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 1921 morgan silver dollar worth Dec 1, 2021 · 23andMe’s shares are down 35% since the merger, leaving a big dent in the fortune of the company’s largest shareholder, cofounder and CEO Anne Wojcicki. The 48-year-old entrepreneur became a ... 23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.